Aim Immunotech Inc AIMID
$9.50
+2.80
(41.79%)
Valuation
- Market cap
- 7,260,000
- Revenue TTM
- $170,000
- Net income TTM
- $-17,320,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -10,188.24%
- Debt to equity
- 0.00
Trading
- Volume
- 5,200
- Avg volume
- 4,391
- Day's range
- $7.70 – $9.80
- Shares out
- 764,000
- Stochastic %K
- 93%
- Beta
- 0.94
- Analysts
- Strong Buy
- Price target
- $125.00
Latest news
No headlines yet.
